Leader in the development of permanent seed brachytherapy in the treatment of cancer.

Investor InformationInvestor Information

Investor Relations

Dwight Babcock
CEO, IsoRay Medical™

Phone: 520-240-4840
dbabcock@isoray.com

This section of the IsoRay website is designed specifically for investors. Please select a link from the left or right-hand side of this window to retrieve the information you are seeking. We thank you for your interest in IsoRay.

Dwight Babcock
CEO, IsoRay Medical™